longevitypulse
Interpret biomarkers, discover evidence-based supplements, build personalized longevity protocols, search clinical trials, and explore Blue Zone and country longevity data through a single API.
Instructions
LongevityPulse: Global longevity intelligence API — biomarker interpretation, supplement evidence, personalized protocols, clinical trials, Blue Zone research, WHO country longevity profiles, epigenetic clocks, dieta
Coverage: Global
Endpoints: • biomarker ($0.15): Biomarker interpretation through longevity science lens • supplement-intel ($0.20): Evidence-graded longevity supplement intelligence • protocol-builder ($0.25): Personalized longevity protocol — exercise, nutrition, sleep, supplements • clinical-trials ($0.10): Search active longevity clinical trials globally from ClinicalTrials.gov • blue-zone ($0.10): Blue Zone intelligence — world longevity hotspots deep-dive • country-longevity ($0.12): WHO country longevity profile — life expectancy, HALE, healthcare, initiatives • epigenetic-clock ($0.20): Epigenetic aging clocks — biological age science, testing, and reversal • diet-intel ($0.15): Evidence-graded dietary analysis for longevity and healthspan • longevity-drug ($0.20): Pharmaceutical longevity intelligence — rapamycin, metformin, senolytics • longevity-clinic ($0.12): Global longevity clinic guide — destinations, treatments, red flags
Input Schema
| Name | Required | Description | Default |
|---|---|---|---|
| age | No | Age in years — e.g. 35 | 52 | 65 | |
| sex | No | Biological sex — male | female | |
| diet | No | Diet pattern — e.g. Mediterranean | time-restricted eating | fasting mimicking diet | Blue Zone plant-based | MIND diet | caloric restriction | ketogenic | Japanese traditional | |
| drug | No | Drug name — e.g. rapamycin | metformin | acarbose | dasatinib | fisetin | senolytics | empagliflozin | semaglutide | |
| lang | No | Response language: en|es|fr|de|ja|zh|ko|pt|ar|hi (default: en) | |
| zone | No | Blue Zone or region — e.g. Okinawa | Sardinia | Ikaria | Nicoya | Loma Linda | Blue Zones overview | Hunza | Vilcabamba | |
| goals | No | Longevity goals — e.g. maximize healthspan | cardiovascular health | cognitive longevity | muscle preservation | reverse biological age | |
| topic | No | Topic — e.g. GrimAge | DunedinPACE | biological age overview | how to reverse biological aging | epigenetic reprogramming | how to test biological age | |
| value | No | Lab result with unit — e.g. 85 mg/dL | 2.1 mg/L | 5.4% | 420 ng/dL (optional — enables personalized assessment) | |
| action | Yes | Which endpoint to call. Options: biomarker | supplement-intel | protocol-builder | clinical-trials | blue-zone | country-longevity | epigenetic-clock | diet-intel | longevity-drug | longevity-clinic | |
| budget | No | Budget level — low | moderate | high | $200/month | |
| country | No | Country name — e.g. Japan | Singapore | Spain | South Korea | Switzerland | Costa Rica | Australia | United States | India | Nigeria | |
| compound | No | Compound name — e.g. NMN | NR | berberine | spermidine | urolithin A | fisetin | quercetin | alpha-ketoglutarate | resveratrol | taurine | |
| biomarker | No | Biomarker name — e.g. ApoB | hs-CRP | HbA1c | testosterone | IGF-1 | homocysteine | Lp(a) | ferritin | vitamin D | DHEA-S | |
| condition | No | Condition or intervention — e.g. aging | rapamycin | metformin | NMN | senolytics | caloric restriction | Alzheimer prevention | |
| treatment | No | Treatment of interest — e.g. stem cell therapy | NAD+ IV | peptide therapy | hyperbaric oxygen | plasmapheresis | ozone therapy | |
| conditions | No | Health conditions — e.g. type 2 diabetes | hypertension | none | |
| recruiting_only | No | Show only recruiting trials (default: true) |